Segal Lloyd Mitchell
Insider CIK 1477123 · RPTX President and CEO, Director · AKTS Director · VRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 50,000 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-12 | 24,687 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-12 | 19,631 | — | $0 | 19,631 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2025-03-12 | 2025-03-14 | 21,179 | $1.14 | $24.1K | 124,394 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2025-03-04 | 2025-03-06 | 237,000 | — | $0 | 237,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award | 2025-03-04 | 2025-03-06 | 40,000 | — | $0 | 145,573 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2024-04-01 | 2024-04-01 | 2,491 | $4.63 | $11.5K | 107,558 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2024-03-28 | 2024-04-01 | 2,650 | $4.62 | $12.2K | 110,049 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2024-03-27 | 2024-03-27 | 2,650 | $4.63 | $12.3K | 83,866 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2024-03-26 | 2024-03-27 | 2,650 | $4.64 | $12.3K | 86,516 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2024-03-25 | 2024-03-27 | 2,650 | $4.79 | $12.7K | 89,166 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2024-03-01 | 2024-03-04 | 237,000 | — | $0 | 237,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award | 2024-03-01 | 2024-03-04 | 40,000 | — | $0 | 124,677 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2023-01-30 | 2023-02-01 | 344,200 | — | $0 | 344,200 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award | 2023-01-30 | 2023-02-01 | 78,550 | — | $0 | 84,677 | SEC↗ |
| RPTX Repare Therapeutics Inc. | M Exercise deriv | 2022-01-21 | 2022-01-24 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | M Exercise deriv | 2022-01-18 | 2022-01-20 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 1,542 | $35.61 | $54.9K | 94,466 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 1,576 | $35.00 | $55.2K | 96,008 | SEC↗ |
| RPTX Repare Therapeutics Inc. | M Exercise deriv | 2021-06-04 | 2021-06-07 | 5,000 | — | $0 | 283,683 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-07 | 12,172 | $31.36 | $381.7K | 97,584 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-07 | 5,000 | $31.25 | $156.3K | 5,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | M Exercise | 2021-06-04 | 2021-06-07 | 5,000 | $1.64 | $8.2K | 10,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-07 | 17,180 | $30.64 | $526.4K | 109,756 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-03 | 2021-06-07 | 6,648 | $31.74 | $211.0K | 126,936 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-20 | 2021-05-21 | 3,770 | $35.03 | $132.1K | 133,584 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-19 | 2021-05-20 | 3,800 | $35.06 | $133.2K | 137,354 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-18 | 2021-05-20 | 1,800 | $35.00 | $63.0K | 141,154 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-04-15 | 2021-04-19 | 5,512 | $35.01 | $193.0K | 142,954 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2021-02-08 | 2021-02-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 5,000 | $20.00 | $100.0K | 5,000 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 354,668 | — | $0 | 354,668 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-14 | 2013-06-18 | 140 | $85.45 | $12.0K | 21,174 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-12 | 2013-06-13 | 2,500 | $83.50 | $208.8K | 21,034 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-11 | 2013-06-13 | 200 | $86.45 | $17.3K | 630 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-11 | 2013-06-13 | 300 | $86.73 | $26.0K | 18,534 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-11 | 2013-06-13 | 90 | $86.48 | $7.8K | 430 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-06-11 | 2013-06-13 | 100 | $86.44 | $8.6K | 340 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer deriv | 2013-05-30 | 2013-06-03 | 36,270 | $90.81 | $3.29M | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | D To issuer | 2013-05-30 | 2013-06-03 | 4,397 | $90.81 | $399.3K | 18,474 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-05-24 | 2013-05-28 | 5,022 | — | $0 | 22,871 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-11-09 | 2012-11-14 | 240 | $54.28 | $13.0K | 17,849 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-11-09 | 2012-11-14 | 240 | $54.28 | $13.0K | 17,849 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2012-11-06 | 2012-11-08 | 745 | $54.44 | $40.6K | 17,609 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-30 | 2012-07-03 | 498 | — | $0 | 16,864 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-06-04 | 2012-06-04 | 8,062 | — | $0 | 16,366 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2012-03-31 | 2012-04-03 | 407 | — | $0 | 8,304 | SEC↗ |